Strategic Blueprint’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $666K | Buy |
1,643
+202
| +14% | +$81.9K | 0.03% | 376 |
|
|
2025
Q1 | $717K | Buy |
1,441
+73
| +5% | +$36.3K | 0.04% | 352 |
|
|
2024
Q4 | $712K | Buy |
1,368
+92
| +7% | +$47.9K | 0.04% | 327 |
|
|
2024
Q3 | $789K | Buy |
1,276
+12
| +0.9% | +$7.42K | 0.05% | 299 |
|
|
2024
Q2 | $699K | Buy |
1,264
+33
| +3% | +$18.2K | 0.05% | 302 |
|
|
2024
Q1 | $715K | Buy |
1,231
+96
| +8% | +$55.8K | 0.05% | 308 |
|
|
2023
Q4 | $602K | Buy |
1,135
+11
| +1% | +$5.84K | 0.05% | 324 |
|
|
2023
Q3 | $569K | Buy |
1,124
+81
| +8% | +$41K | 0.05% | 313 |
|
|
2023
Q2 | $544K | Buy |
1,043
+180
| +21% | +$93.9K | 0.05% | 307 |
|
|
2023
Q1 | $497K | Buy |
863
+5
| +0.6% | +$2.88K | 0.05% | 310 |
|
|
2022
Q4 | $472K | Buy |
858
+8
| +0.9% | +$4.4K | 0.05% | 308 |
|
|
2022
Q3 | $431K | Buy |
850
+11
| +1% | +$5.58K | 0.05% | 302 |
|
|
2022
Q2 | $456K | Buy |
839
+284
| +51% | +$154K | 0.06% | 288 |
|
|
2022
Q1 | $328K | Buy |
555
+50
| +10% | +$29.6K | 0.04% | 367 |
|
|
2021
Q4 | $337K | Buy |
505
+50
| +11% | +$33.4K | 0.04% | 352 |
|
|
2021
Q3 | $260K | Sell |
455
-144
| -24% | -$82.3K | 0.04% | 350 |
|
|
2021
Q2 | $302K | Buy |
+599
| New | +$302K | 0.05% | 294 |
|
|
2019
Q4 | – | Sell |
-21
| Closed | -$6K | – | 386 |
|
|
2019
Q3 | $6K | Buy |
+21
| New | +$6K | ﹤0.01% | 350 |
|